Welcome to our dedicated page for Diversified Healthcare Trust SEC filings (Ticker: DHCNL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Diversified Healthcare Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Diversified Healthcare Trust's regulatory disclosures and financial reporting.
JONES LISA HARRIS reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST director Lisa Harris Jones received 12,401 Common Shares of Beneficial Interest as an equity award. The shares were granted at no cash cost under the company’s equity compensation plan, bringing her direct holdings to about 170,287 shares. This total includes 392.041 shares accumulated through a dividend reinvestment plan.
JONES LISA HARRIS reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST director Lisa Harris Jones received 12,401 Common Shares of Beneficial Interest as an equity award. The shares were granted at no cash cost under the company’s equity compensation plan, bringing her direct holdings to about 170,287 shares. This total includes 392.041 shares accumulated through a dividend reinvestment plan.
SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.
SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.
Neher Dawn K. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Dawn K. Neher received an award of 12,401 Common Shares of Beneficial Interest as equity compensation. The shares were granted at no cash cost to her under the company’s equity compensation plan and increase her direct holdings to 78,579 shares.
Neher Dawn K. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Dawn K. Neher received an award of 12,401 Common Shares of Beneficial Interest as equity compensation. The shares were granted at no cash cost to her under the company’s equity compensation plan and increase her direct holdings to 78,579 shares.
Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust President and CEO Christopher J. Bilotto received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 at no cash cost, as part of the company’s equity compensation plan. After this grant and shares added through a dividend reinvestment plan, his direct holdings total about 279,246.802 shares, including 560.894 shares accumulated from reinvested dividends since his last ownership report.
Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust President and CEO Christopher J. Bilotto received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 at no cash cost, as part of the company’s equity compensation plan. After this grant and shares added through a dividend reinvestment plan, his direct holdings total about 279,246.802 shares, including 560.894 shares accumulated from reinvested dividends since his last ownership report.
PORTNOY ADAM D. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Adam D. Portnoy reported an equity-based compensation grant and updated holdings. He received 12,401 Common Shares of Beneficial Interest as an award under the company’s equity compensation plan, bringing his directly held stake to 427,557.55 shares.
The filing also lists 23,250,019 Common Shares of Beneficial Interest held indirectly through ABP Trust. Mr. Portnoy, as sole trustee, officer and controlling shareholder of ABP Trust, may be deemed a beneficial owner of those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
PORTNOY ADAM D. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Adam D. Portnoy reported an equity-based compensation grant and updated holdings. He received 12,401 Common Shares of Beneficial Interest as an award under the company’s equity compensation plan, bringing his directly held stake to 427,557.55 shares.
The filing also lists 23,250,019 Common Shares of Beneficial Interest held indirectly through ABP Trust. Mr. Portnoy, as sole trustee, officer and controlling shareholder of ABP Trust, may be deemed a beneficial owner of those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Felder Alan L. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Alan L. Felder received an award of 12,401 Common Shares of Beneficial Interest on 2026-06-10. The shares were granted at no cash cost to him pursuant to the company’s equity compensation plan.
Following this grant, Felder directly holds 75,124 common shares, as reported in the filing.
Felder Alan L. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Alan L. Felder received an award of 12,401 Common Shares of Beneficial Interest on 2026-06-10. The shares were granted at no cash cost to him pursuant to the company’s equity compensation plan.
Following this grant, Felder directly holds 75,124 common shares, as reported in the filing.
Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Phyllis M. Hollis received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The award was granted at no cash cost per share as part of her director compensation.
After this grant, she directly holds 100,147.703 common shares. This total includes 666.634 shares accumulated through a dividend reinvestment plan since her prior Section 16 filing, showing ongoing participation in the company’s reinvestment program in addition to the new equity award.
Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Phyllis M. Hollis received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The award was granted at no cash cost per share as part of her director compensation.
After this grant, she directly holds 100,147.703 common shares. This total includes 666.634 shares accumulated through a dividend reinvestment plan since her prior Section 16 filing, showing ongoing participation in the company’s reinvestment program in addition to the new equity award.
Diversified Healthcare Trust held its annual shareholder meeting on June 10, 2026, where shareholders elected seven Trustees to one-year terms ending at the 2027 annual meeting. All nominees, including Christopher J. Bilotto, Alan Felder and Adam Portnoy, received more votes for than withheld.
Shareholders approved a non-binding advisory vote on the compensation of named executive officers, with 176,612,032 votes for and 8,812,215 against. They also ratified Deloitte & Touche LLP as independent auditors for the 2026 fiscal year, with 202,537,283 votes in favor and minimal opposition.
Diversified Healthcare Trust held its annual shareholder meeting on June 10, 2026, where shareholders elected seven Trustees to one-year terms ending at the 2027 annual meeting. All nominees, including Christopher J. Bilotto, Alan Felder and Adam Portnoy, received more votes for than withheld.
Shareholders approved a non-binding advisory vote on the compensation of named executive officers, with 176,612,032 votes for and 8,812,215 against. They also ratified Deloitte & Touche LLP as independent auditors for the 2026 fiscal year, with 202,537,283 votes in favor and minimal opposition.
Diversified Healthcare Trust filed a current report to let investors know it has made a new investor presentation available. On June 1, 2026, the company posted this presentation on its website and attached it as Exhibit 99.1 to the report, where it is furnished for reference.
Diversified Healthcare Trust filed a current report to let investors know it has made a new investor presentation available. On June 1, 2026, the company posted this presentation on its website and attached it as Exhibit 99.1 to the report, where it is furnished for reference.
Diversified Healthcare Trust furnished a new investor presentation, dated May 5, 2026, and made it available on its website. The presentation is attached as Exhibit 99.1 to this Form 8-K. This is an informational update rather than a disclosure of specific new financial results or major transactions.
Diversified Healthcare Trust furnished a new investor presentation, dated May 5, 2026, and made it available on its website. The presentation is attached as Exhibit 99.1 to this Form 8-K. This is an informational update rather than a disclosure of specific new financial results or major transactions.